Skip to main content
. Author manuscript; available in PMC: 2020 Jan 10.
Published in final edited form as: J Invest Dermatol. 2008 Nov;128(11):2596–2605. doi: 10.1038/jid.2008.101

Figure 1. Strategy for immunotherapy of melanoma.

Figure 1.

CTL, cytotoxic T lymphocyte; DLN, draining lymph node; PBMC, peripheral blood mononuclear cells; CTLA, cytotoxic T lymphocyte antigen; TIL, tumor-infiltrating lymphocyte; HSC, hematopoietic stem cell.